PHASE IB DOSE-ESCALATION STUDY OF BEZ235 OR BKM120 IN COMBINATION WITH PACLITAXEL (PTX) IN PATIENTS WITH ADVANCED SOLID TUMORS

被引：0
|
作者：
Dirix, L. [1 ]
Schuler, M. [2 ]
Machiels, J. [3 ]
Hess, D. [4 ]
Awada, A. [5 ]
Steeghs, N. [6 ]
Paz-Ares, L. [7 ]
von Moos, R. [8 ]
Rabault, B. [9 ]
Rodon, J. [10 ]
机构：
[1] Sint Augustinus Hosp, Antwerp, Belgium
[2] Univ Klinikum Essen, Westdeutsch Tumorzentrum, Essen, Germany
[3] Clin Univ St Luc, Dept Med Oncol, B-1200 Brussels, Belgium
[4] Kantonsspital St Gallen, St Gallen, Switzerland
[5] Inst Jules Bordet, Dept Med Oncol, B-1000 Brussels, Belgium
[6] Netherlands Canc Inst, Amsterdam, Netherlands
[7] Univ Hosp Virgen del Rocio, Seville, Spain
[8] Kantonsspital Graubunden, Chur, Switzerland
[9] Novartis Pharma AG, Oncol, Basel, Switzerland
[10] Vall dHebron Univ Hosp, Barcelona, Spain
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：157 / 158
页数：2
相关论文
共 50 条
  • [41] Phase I Dose-Escalation Study of Ramucirumab in Chinese Patients with Advanced Solid Tumors
    Cao, Junning
    Ji, Dongmei
    Chen, Zhiyu
    Shen, Weina
    Wang, Jin
    Li, Baoyue
    Chi, Haidong
    Long, Amanda
    Gao, Ling
    Li, Jin
    ONCOLOGIST, 2017, 22 (06): : 638 - +
  • [42] Phase I Dose-Escalation and Pharmacokinetic Study of Dasatinib in Patients with Advanced Solid Tumors
    Demetri, George D.
    Lo Russo, Patricia
    MacPherson, Lain R. J.
    Wang, Ding
    Morgan, Jeffrey A.
    Brunton, Valerie G.
    Paliwal, Prashni
    Agrawal, Shruti
    Voi, Maurizio
    Evan, T. R. Jeffry
    CLINICAL CANCER RESEARCH, 2009, 15 (19) : 6232 - 6240
  • [43] A Phase 1 Dose-Escalation Study of Low-Dose Metronomic Treatment With Novel Oral Paclitaxel Formulations in Combination With Ritonavir in Patients With Advanced Solid Tumors
    de Weger, Vincent A.
    Vermunt, Marit A. C.
    Stuurman, Frederik E.
    Burylo, Artur M.
    Damoiseaux, David
    Hendrikx, Jeroen J. M. A.
    Sawicki, Emilia
    Moes, Johannes J.
    Huitema, Alwin D. R.
    Nuijen, Bastiaan
    Rosing, Hilde
    Mergui-Roelvink, Marja
    Beijnen, Jos H.
    Marchetti, Serena
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2021, 10 (06): : 607 - 621
  • [44] A phase Ib dose-escalation study of troriluzole (BHV-4157), an oral glutamatergic signaling modulator, in combination with nivolumab in patients with advanced solid tumors
    Silk, Ann W.
    Saraiya, Biren
    Groisberg, Roman
    Chan, Nancy
    Spencer, Kristen
    Girda, Eugenia
    Shih, Weichung
    Palmeri, Marisa
    Saunders, Tracie
    Berman, Robert M.
    Coric, Vlad
    Chen, Suzie
    Zloza, Andrew
    Vieth, Joshua
    Mehnert, Janice M.
    Malhotra, Jyoti
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2022, 27 (01)
  • [45] A phase Ib dose-escalation study of troriluzole (BHV-4157), an oral glutamatergic signaling modulator, in combination with nivolumab in patients with advanced solid tumors
    Ann W. Silk
    Biren Saraiya
    Roman Groisberg
    Nancy Chan
    Kristen Spencer
    Eugenia Girda
    Weichung Shih
    Marisa Palmeri
    Tracie Saunders
    Robert M. Berman
    Vlad Coric
    Suzie Chen
    Andrew Zloza
    Joshua Vieth
    Janice M. Mehnert
    Jyoti Malhotra
    European Journal of Medical Research, 27
  • [46] A phase Ib dose-escalation study of eribulin mesylate in combination with capecitabine in patients with advanced/metastatic cancer
    Nasim, Muhammad Yaser
    Plummer, Ruth
    Evans, T. R. Jeffry
    Morrison, Rosemary
    Anthoney, David Alan
    Haney, Sophie
    Madi, Ayman
    Savulsky, Claudio Isaac
    Johnston, Claire
    Carter, David
    Reyderman, Larisa
    Gopalakrishna, Prashanth
    Wanders, Jantien
    Twelves, Christopher
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [47] Phase Ia/Ib dose-escalation study of the anti-TIGIT antibody tiragolumab as a single agent and in combination with atezolizumab in patients with advanced solid tumors
    Bendell, Johanna C.
    Bedard, Philippe
    Bang, Yung-Jue
    LoRusso, Patricia
    Hodi, Stephen
    Gordon, Michael
    D'Angelo, Sandra
    Desai, Jayesh
    Garralda, Elena
    Italiano, Antoine
    Myung-Ju Ahn
    Cervantes, Andres
    Wainberg, Zev
    Calvo, Emiliano
    Gil-Martin, Marta
    Martinez-Garcia, Maria
    Bahleda, Rastilav
    Cassier, Philippe
    Delord, Jean-Pierre
    Prawira, Amy
    Melero, Ignacio
    Emens, Leisha
    Romano, Emanuela
    Miller, Karen
    Hsieh, Robert W.
    Xue, Cloris
    Morrissey, Kari
    Twomey, Patrick
    Gash, Kelly
    Patil, Namrata S.
    Grogan, Jane
    Meng, Raymond
    Cho, Byoung
    Kim, Tae Won
    CANCER RESEARCH, 2020, 80 (16)
  • [48] Phase Ib dose-escalation study of MetMAb, a monovalent antagonist antibody to the receptor MET, in combination with bevacizumab in patients with locally advanced or metastatic solid tumors
    Moss, R. A.
    Bothos, J. G.
    Filvaroff, E.
    Merchant, M.
    Eppler, S.
    Yu, W.
    Harris, K.
    Scott, P.
    Mehnert, J. M.
    Patel, P. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [49] A dose-escalation study of oxaliplatin and vinorelbine in patients with advanced solid tumors
    Kakolyris, S
    Kouroussis, C
    Koukourakis, M
    Marvroudis, D
    Malas, K
    Vardakis, N
    Bozionelou, V
    Kalbakis, K
    Georgoulias, V
    ONCOLOGY, 2002, 63 (03) : 213 - 218
  • [50] A dose-escalation study of oxaliplatin and vinorelbine in patients with advanced solid tumors'
    Kakolyris
    ONCOLOGY, 2006, 71 (3-4) : 203 - 203
12345